Kate Dixon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation”.

Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation

Frontiers in Immunology(2021)10.3389/fimmu.2021.711621

N/A

0DataRank · unranked

25 citations

Kate Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce Walcheck +1 more

MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection

Molecular Immunology(2021)10.1016/j.molimm.2021.07.001

N/A

0DataRank · unranked

7 citations

Jason Siebert, Dandan Wang, Alex Abel, K. E. Johnson, Matthew J. Riese +5 more

197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.197

N/A

0DataRank · unranked

0 citations

Kate Dixon, Melissa Khaw, Zachary Davis, Paul Rogers, Martin Hosking +5 more

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008959

N/A

0DataRank · unranked

11 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more

Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.09.593347

N/A

0DataRank · unranked

1 citations

Rob H. Hullsiek, Kate Dixon, Sam C. Wang, Anders Lindstedt, Ryan R. Friess +8 more